Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Verrica Pharmaceuticals
Verrica Pharmaceuticals
(VRCA)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Ycanth
Cantharidin
2023-07-21
2035-2038
Warts
,
Molluscum contagiosum
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Cantharidin
infections
,
papillomavirus infections
,
communicable diseases
,
virus diseases
,
infectious skin diseases
,
skin diseases
,
warts
,
viral skin diseases
,
sexually transmitted diseases
,
condylomata acuminata
,
viral sexually transmitted diseases
,
tumor virus infections
,
dna virus infections
,
molluscum contagiosum
Salicylic acid
infections
,
papillomavirus infections
,
communicable diseases
,
virus diseases
,
infectious skin diseases
,
skin diseases
,
tumor virus infections
,
warts
,
dna virus infections
,
viral skin diseases
Ademetionine
infections
,
papillomavirus infections
,
communicable diseases
,
virus diseases
,
infectious skin diseases
,
skin diseases
,
sexually transmitted diseases
,
warts
,
condylomata acuminata
,
viral sexually transmitted diseases
,
viral skin diseases
,
molluscum contagiosum
RUXOTEMITIDE
carcinoma
,
neoplasms
,
basal cell carcinoma
,
skin neoplasms
,
basal cell neoplasms
Std
infections
,
papillomavirus infections
,
communicable diseases
,
virus diseases
,
infectious skin diseases
,
skin diseases
,
sexually transmitted diseases
,
warts
,
condylomata acuminata
,
viral sexually transmitted diseases
,
viral skin diseases
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use